Compare RANI & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RANI | ACU |
|---|---|---|
| Founded | 2012 | 1867 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.7M | 154.0M |
| IPO Year | 2021 | N/A |
| Metric | RANI | ACU |
|---|---|---|
| Price | $1.24 | $43.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $8.67 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 8.8K |
| Earning Date | 03-30-2026 | 02-27-2026 |
| Dividend Yield | N/A | ★ 1.46% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.45 |
| Revenue | $1,200,000.00 | ★ $194,960,991.00 |
| Revenue This Year | $414.59 | $2.19 |
| Revenue Next Year | $30.15 | $4.55 |
| P/E Ratio | ★ N/A | $17.87 |
| Revenue Growth | N/A | ★ 2.35 |
| 52 Week Low | $0.39 | $35.32 |
| 52 Week High | $3.87 | $45.25 |
| Indicator | RANI | ACU |
|---|---|---|
| Relative Strength Index (RSI) | 43.79 | 55.87 |
| Support Level | $1.07 | $43.26 |
| Resistance Level | $1.42 | $45.20 |
| Average True Range (ATR) | 0.09 | 1.20 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 49.28 | 66.87 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.